Manuj K Nangia, MD
Psychiatry · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 4 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
21 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nangia’s office at (408) 357-0105 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
California Medical Board record
Licence A91711 · Current
Licensed to practise in California · since 2005 · expires 2029-02-28 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$82,084
Medicare paid this office $82,084 for 32 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | 13 | $61,604 | $116 |
| Short return visit (20+ min) | 22 | $5,923 | $85 |
| Psychotherapy with evaluation and management visit, 30 minutes | 27 | $5,464 | $61 |
| Psychiatric diagnostic evaluation with medical services | 18 | $2,970 | $165 |
| Return visit (30+ min) | 13 | $2,345 | $112 |
Who their Medicare patients are
32 Original Medicare patients in 2024. Average age 68 · 85 and older 0% · Health risk score 1.00. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 63%.
The office billed $631,338, Medicare allowed $103,822 and paid $82,084; for 750 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 32 | 750 | 68 | 1.00 | $631,338 | $82,084 |
| 2023 | 23 | 537 | 65 | 1.13 | $455,011 | $61,273 |
| 2022 | 17 | 266 | 68 | 0.57 | $228,763 | $31,295 |
| 2017 | 18 | 102 | 69 | 2.30 | $24,056 | $7,224 |
| 2016 | 21 | 200 | 58 | 1.55 | $46,080 | $13,189 |
| 2014 | 29 | 127 | 58 | 1.39 | $35,401 | $10,697 |
| 2013 | 22 | 205 | 58 | 1.55 | $45,890 | $11,499 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | 12 | $52,049 | $117 |
| Short return visit (20+ min) | 15 | $2,467 | $82 |
| Psychotherapy with evaluation and management visit, 30 minutes | 17 | $2,126 | $59 |
2017: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,786 | $65 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $2,389 | $57 |
| Psychiatric diagnostic evaluation with medical services | 15 | $1,863 | $124 |
2016: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $6,793 | $62 |
| Psychotherapy with evaluation and management visit, 30 minutes | 13 | $3,214 | $54 |
| Psychiatric diagnostic evaluation with medical services | 18 | $2,123 | $118 |
2014: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $5,700 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,957 | $180 |
2013: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $5,822 | $63 |
| Psychotherapy with evaluation and management visit, 30 minutes | 17 | $2,842 | $32 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,149 | $104 |
Drugs they prescribed that Part D paid
$6,214
Pharmacies billed $6,214 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 248) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
246 generic and fewer than 11 brand-name prescriptions · $6,214 in drug cost · 33 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mirtazapine | 18 | $591 | $33 |
| Methylphenidate | 11 | $449 | $41 |
| Olanzapine | 11 | $440 | $40 |
| Bupropion Xl | 22 | $308 | $14 |
| Escitalopram | 22 | $256 | $12 |
See all 10 drugs
| Mirtazapine | 18 | $591 | $33 |
| Methylphenidate | 11 | $449 | $41 |
| Olanzapine | 11 | $440 | $40 |
| Bupropion Xl | 22 | $308 | $14 |
| Escitalopram | 22 | $256 | $12 |
| Fluoxetine | 19 | $244 | $13 |
| Duloxetine | 17 | $215 | $13 |
| Lamotrigine | 14 | $182 | $13 |
| Doxepin | 12 | $178 | $15 |
| Trazodone | 17 | $117 | $7 |
Year by year
| 2024 | 248 | 26 | 0% (0) | None | $6,214 |
| 2023 | 149 | 18 | 0% (0) | 0% | $9,118 |
| 2022 | 95 | 15 | 0% (0) | 0% | $4,788 |
| 2021 | 164 | 20 | 0% (0) | 9% | $18,585 |
| 2020 | 105 | None | 0% (0) | 11% | $24,018 |
| 2019 | 69 | None | 0% (0) | None | $10,047 |
| 2018 | 87 | None | 0% (0) | None | $6,366 |
| 2017 | 62 | None | 0% (0) | 0% | $1,519 |
| 2016 | 157 | 30 | 0% (0) | None | $15,669 |
| 2015 | 225 | 28 | 0% (0) | 10% | $37,848 |
| 2014 | 116 | 18 | 0% (0) | 21% | $23,094 |
| 2013 | 87 | 24 | 0% (0) | 23% | $17,842 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Lamotrigine | 12 | $623 | $52 |
| Methylphenidate | 11 | $359 | $33 |
| Trazodone | 16 | $304 | $19 |
2022: 2 drugs
| Trazodone | 13 | $171 | $13 |
| Clozapine | 13 | $170 | $13 |
2021: 2 drugs
| Duloxetine | 12 | $828 | $69 |
| Trazodone | 26 | $394 | $15 |
2020: 1 drug
| Lamotrigine | 13 | $128 | $10 |
2019: 2 drugs
| Bupropion Hcl Sr | 15 | $209 | $14 |
| Venlafaxine Hcl Er | 12 | $143 | $12 |
2018: 4 drugs
| Bupropion Hcl Sr | 18 | $414 | $23 |
| Duloxetine | 12 | $252 | $21 |
| Quetiapine | 17 | $150 | $9 |
| Venlafaxine Hcl Er | 11 | $71 | $6 |
2017: 1 drug
| Duloxetine | 12 | $335 | $28 |
2016: 3 drugs
| Aripiprazole | 16 | $4,722 | $295 |
| Quetiapine | 39 | $540 | $14 |
| Trazodone | 12 | $86 | $7 |
2015: 8 drugs
| Abilify | 13 | $15,587 | $1,199 |
| Divalproex Sodium Er | 13 | $1,365 | $105 |
| Duloxetine | 12 | $1,013 | $84 |
| Quetiapine | 47 | $835 | $18 |
| Haloperidol | 15 | $591 | $39 |
| Bupropion Xl | 14 | $361 | $26 |
| Venlafaxine Hcl Er | 11 | $89 | $8 |
| Risperidone | 11 | $71 | $6 |
2014: 2 drugs
| Abilify | 16 | $17,593 | $1,100 |
| Quetiapine | 22 | $2,195 | $100 |
2013: 2 drugs
| Abilify | 13 | $12,298 | $946 |
| Olanzapine | 11 | $1,361 | $124 |
Money from drug and device companies
$439 in 2025
| 2025 | 9 | 14 | None | $439 |
| 2024 | 5 | 17 | None | $446 |
| 2023 | 2 | 16 | None | $206 |
| 2022 | 13 | 47 | None | $851 |
| 2021 | 19 | 61 | None | $1,189 |
| 2020 | 17 | 111 | None | $1,985 |
| 2019 | 13 | 76 | None | $1,549 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Cobenfy | $196 | 4 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $50 | 2 payments
|
| Neuronetics | Neurostar Tms Therapy System | $41 | 2 payments
|
| Axsome Therapeutics | Auvelity | $30 | 1 payment
|
| Alkermes | Aristada | $30 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $29 | 1 payment
|
See all 14 published payments
| Otsuka America Pharmaceutical | Meals · 2025-10-17 | Rexulti | $29 |
| Braeburn | Meals · 2025-10-08 | Brixadi | $23 |
| Alkermes | Meals · 2025-09-17 | Aristada | $30 |
| Janssen Pharmaceuticals | Meals · 2025-06-19 | Invega Sustenna | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-30 | Cobenfy | $26 |
| Neuronetics | Meals · 2025-04-18 | Neurostar Tms Therapy System | $20 |
| Indivior | Meals · 2025-03-27 | Sublocade | $22 |
| Axsome Therapeutics | Meals · 2025-03-20 | Auvelity | $30 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-05 | Cobenfy | $26 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-20 | Cobenfy | $133 |
| Janssen Pharmaceuticals | Meals · 2025-02-19 | Spravato | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-12 | Cobenfy | $11 |
| Neuronetics | Meals · 2025-01-24 | Neurostar Tms Therapy System | $21 |
| Abbvie | Meals · 2025-01-03 | Vraylar | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $446
| Teva Pharmaceuticals USA | Uzedy | $185 | 4 payments
|
| Abbvie | Vraylar | $155 | 8 payments
|
| Masimo | Patient Safetynet System | $50 | 2 payments
|
| Indivior | Sublocade | $35 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $21 | 1 payment
|
2023: $206
| Abbvie | Vraylar | $171 | 15 payments
|
| Axsome Therapeutics | Auvelity | $35 | 1 payment
|
2022: $851
| Abbvie | Vraylar | $179 | 14 payments
|
| Lundbeck | Rexulti | $122 | 7 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $120 | 7 payments
|
| Bausch Health US | Aplenzin | $100 | 4 payments
|
| Iti | Caplyta | $86 | 4 payments
|
| Alkermes | Aristada | $71 | 3 payments
|
| Alfasigma USA | None | $47 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $27 | 1 payment
|
| Eisai | Dayvigo | $27 | 1 payment
|
| Vanda Pharmaceuticals | Hetlioz | $20 | 1 payment
|
| Merck Sharp & Dohme | Belsomra | $20 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $17 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $14 | 1 payment
|
2021: $1,189
| AbbVie | Vraylar | $179 | 15 payments
|
| Lundbeck | Brintellix | $143 | 10 payments
|
| Neuronetics | Neurostar Tms Therapy | $140 | 4 payments
|
| Iti | Caplyta | $125 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $97 | 5 payments
|
| Otsuka America Pharmaceutical | Rexulti | $79 | 4 payments
|
| Eisai | Dayvigo | $59 | 3 payments
|
| Vanda Pharmaceuticals | Fanapt | $55 | 2 payments
|
| Merck Sharp & Dohme | Belsomra | $48 | 2 payments
|
| Sunovion Pharmaceuticals | Latuda | $45 | 2 payments
|
| Teva Pharmaceuticals USA | Austedo | $38 | 2 payments
|
| Alfasigma USA | None | $31 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $30 | 1 payment
|
| Bausch Health US | Aplenzin | $26 | 1 payment
|
| Indivior | Sublocade | $22 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $22 | 1 payment
|
| Sage Therapeutics | Zulresso | $19 | 1 payment
|
| Jazz Pharmaceuticals | Sunosi | $18 | 1 payment
|
| Adlon Therapeutics L.P. | Adhansia Xr | $15 | 1 payment
|
2020: $1,985
| Neuronetics | Neurostar Tms Therapy | $307 | 10 payments
|
| Allergan | Vraylar | $294 | 22 payments
|
| Lundbeck | Rexulti | $240 | 16 payments
|
| Sunovion Pharmaceuticals | Latuda | $152 | 14 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $146 | 9 payments
|
| Neurocrine Biosciences | Ingrezza | $137 | 6 payments
|
| Janssen Pharmaceuticals | Spravato | $136 | 6 payments
|
| Vanda Pharmaceuticals | Fanapt | $130 | 6 payments
|
| Teva Pharmaceuticals USA | Austedo | $105 | 5 payments
|
| Iti | Caplyta | $90 | 4 payments
|
| Orexo US | Zubsolv | $61 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $57 | 3 payments
|
| Bausch Health US | Wellbutrin | $54 | 3 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $24 | 1 payment
|
| Eisai | Dayvigo | $23 | 1 payment
|
| Alkermes | Aristada | $17 | 1 payment
|
| Adlon Therapeutics L.P. | Adhansia Xr | $14 | 1 payment
|
2019: $1,549
| Neuronetics | Neurostar Tms Therapy | $535 | 15 payments
|
| Otsuka America Pharmaceutical | Rexulti | $232 | 18 payments
|
| Allergan | Vraylar | $148 | 9 payments
|
| Lundbeck | Rexulti | $148 | 8 payments
|
| Sunovion Pharmaceuticals | Latuda | $129 | 9 payments
|
| Alkermes | Aristada | $79 | 4 payments
|
| Neurocrine Biosciences | Ingrezza | $77 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $66 | 3 payments
|
| Vanda Pharmaceuticals | Hetlioz | $45 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $29 | 1 payment
|
| Shire North American Group | Vyvanse | $27 | 2 payments
|
| Bausch Health US | Wellbutrin | $17 | 1 payment
|
| Ironshore Pharmaceuticals | Jornay Pm 20mg Capsules (Bottle of 100) | $17 | 1 payment
|
Professional record
- NPI
- 1437283405
- Licence
- CA A91711California A91711: Current · expires 2029-02-28
- Trained
- University of Southern California Keck School of Medicine, 2003
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A917110
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 825 Pollard Rd Ste 108, Los Gatos, CA, 95032
- NPI first listed
- 2007-03-14
- NPI last updated
- 2023-01-18
- NPI record certified
- 2022-12-13
This is when the NPI record was last certified, not a medical board exam.